Genetic variants that can determine which early stage tumors will progress to an aggressive form of the disease can change decision making for clinicians, patients, and their families.
Genetic variants that can determine which early stage tumors will progress to an aggressive form of the disease can change decision making for clinicians, patients, and their families.